Investigating the effect of dexmedetomidine on recovery indicators after rhinoplasty surgery
Phase 3
Recruiting
- Conditions
- Rhinoplasty.Other and unspecified disorders of nose and nasal sinuses
- Registration Number
- IRCT20200825048515N57
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age range18 to 65 years
Rhinoplasty surgery candidate under general anesthesia
American Society of Anesthesiology (ASA) class one and two
Consent to participate in the study
Exclusion Criteria
Addiction
The history of previous allergy to dexmedetomidine
body mass index (BMI) above 30 kg/m2
Taking painkillers or neuropsychiatric drugs before the intervention
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Immediately after entering recovery and then every 15 minutes until leaving recovery. Method of measurement: Visual Analogue Scale.;Chilling. Timepoint: Immediately after entering recovery and then every 15 minutes until leaving recovery. Method of measurement: Based on the shivering criterion (0: no shivering / 1: weak fasciculation of face and neck muscles / 2: visible tremor in more than one muscle group).;Restlessness. Timepoint: Immediately after entering recovery and then every 15 minutes until leaving recovery. Method of measurement: Riker sedation-agitation scale.
- Secondary Outcome Measures
Name Time Method ausea. Timepoint: Immediately after entering recovery and then every 15 minutes until leaving recovery. Method of measurement: 0: not having nausea, 1: mild nausea, 2: moderate nausea, and 3: sever nausea.;Vomiting. Timepoint: Immediately after entering recovery and then every 15 minutes until leaving recovery. Method of measurement: 0: no vomiting, 1: little vomiting, 2: vomiting gastric contents, and 3: vomiting of food particles.